Frailty Is an Independent Risk Factor for Mortality, Cardiovascular Disease, Bone Disease, and Diabetes Among Aging Adults With Human Immunodeficiency Virus
- PMID: 30590451
- PMCID: PMC6938206
- DOI: 10.1093/cid/ciy1101
Frailty Is an Independent Risk Factor for Mortality, Cardiovascular Disease, Bone Disease, and Diabetes Among Aging Adults With Human Immunodeficiency Virus
Abstract
Background: We characterized associations between frailty and incident cardiovascular disease (CVD), diabetes mellitus (DM), bone disease, and mortality within a cohort of aging persons with human immunodeficiency virus (PWH).
Methods: Participants underwent frailty evaluations using the Fried frailty assessment (baseline and annually). Frailty was defined as having ≥3 frailty criteria. Clinical outcomes of mortality, CVD events, DM, and bone disease events were recorded throughout the study period (baseline to most recent study or clinic visit, or date of clinical outcome, whichever came first). Poisson regression models were used to evaluate associations between baseline frailty, change in frailty score over 48 weeks, and each clinical outcome.
Results: Among 821 men and 195 women (median age 51 years), 62 (6%) were frail at baseline. Frailty scores increased by ≥1 component among 194 participants (19%) from baseline to 48 weeks. Baseline frailty was associated with an increased risk of incident CVD and DM, with a trend toward a significant association with bone events. Among frailty components, slow gait speed was associated with incident DM and borderline associated with incident CVD. An increase in frailty from baseline to week 48 was associated with mortality but not with the other clinical outcomes.
Conclusions: Baseline frailty was associated with multiple adverse health outcomes (incident CVD, DM, and bone disease), while increase in frailty score was associated with mortality among PWH engaged in care. Incorporation of frailty assessments into the care of PWH may assist in improvement of functional status and risk stratification for age-related chronic diseases.
Keywords: chronic diseases; frailty; human immunodeficiency virus; mortality.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Figures
Comment in
-
Frailty Is Associated With Insulin Resistance in Chronic Human Immunodeficiency Virus Infection.Clin Infect Dis. 2020 Aug 14;71(4):1127-1128. doi: 10.1093/cid/ciz1017. Clin Infect Dis. 2020. PMID: 31612202 Free PMC article. No abstract available.
References
-
- Palella FJ Jr, Delaney KM, Moorman AC, et al. . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853–60. - PubMed
-
- Palella FJ Jr, Baker RK, Moorman AC, et al. ; HIV Outpatient Study Investigators Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006; 43:27–34. - PubMed
-
- Bergersen BM, Sandvik L, Bruun JN, Tonstad S. Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects. Eur J Clin Microbiol Infect Dis 2004; 23:625–30. - PubMed
-
- Guaraldi G, Orlando G, Zona S, et al. . Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011; 53:1120–6. - PubMed
-
- Rodger AJ, Lodwick R, Schechter M, et al. ; INSIGHT SMART, ESPRIT Study Groups Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS 2013; 27:973–9. - PubMed
Publication types
MeSH terms
Grants and funding
- UM1 AI069494/AI/NIAID NIH HHS/United States
- UM1 AI106701/AI/NIAID NIH HHS/United States
- P30 DK048520/DK/NIDDK NIH HHS/United States
- UM1 AI069432/AI/NIAID NIH HHS/United States
- K23 AG050260/AG/NIA NIH HHS/United States
- U01 AI038855/AI/NIAID NIH HHS/United States
- R01 AG054366/AG/NIA NIH HHS/United States
- UM1 AI068634/AI/NIAID NIH HHS/United States
- U01 AI068636/AI/NIAID NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
- U01 AI068634/AI/NIAID NIH HHS/United States
- UM1 AI068636/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
